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Background: Amelogenesis imperfecta (AI) is an inherited disorder characterized by abnormal formation of tooth
enamel. Although several genes responsible for AI have been reported, not all causative genes for human AI have
been identified to date. AMI rat has been reported as an autosomal recessive mutant with hypoplastic AI isolated
from a colony of stroke-prone spontaneously hypertensive rat strain, but the causative gene has not yet been
clarified. Through a genetic screen, we identified the causative gene of autosomal recessive AI in AMI and analyzed
its role in amelogenesis.
Methods: cDNA sequencing of possible AI-candidate genes so far identified using total RNA of day 6 AMI rat
molars identified a novel responsible mutation in specificity protein 6 (Sp6). Genetic linkage analysis was performed
between Sp6 and AI phenotype in AMI. To understand a role of SP6 in AI, we generated the transgenic rats
harboring Sp6 transgene in AMI (Ami/Ami+ Tg). Histological analyses were performed using the thin sections of
control rats, AMI, and Ami/Ami+ Tg incisors in maxillae, respectively.
Results: We found the novel genetic linkage between a 2-bp insertional mutation of Sp6 gene and the AI
phenotype in AMI rats. The position of mutation was located in the coding region of Sp6, which caused frameshift
mutation and disruption of the third zinc finger domain of SP6 with 11 cryptic amino acid residues and a stop
codon. Transfection studies showed that the mutant protein can be translated and localized in the nucleus in the
same manner as the wild-type SP6 protein. When we introduced the CMV promoter-driven wild-type Sp6 transgene
into AMI rats, the SP6 protein was ectopically expressed in the maturation stage of ameloblasts associated with the
extended maturation stage and the shortened reduced stage without any other phenotypical changes.
Conclusion: We propose the addition of Sp6 mutation as a new molecular diagnostic criterion for the autosomal
recessive AI patients. Our findings expand the spectrum of genetic causes of autosomal recessive AI and sheds light
on the molecular diagnosis for the classification of AI. Furthermore, tight regulation of the temporospatial
expression of SP6 may have critical roles in completing amelogenesis.
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Amelogenesis imperfecta (AI) is a genetic disorder charac-
terized by morphological and functional defects of tooth
enamel formation. AI disease entity has been classified
into four types: hypoplastic, hypocalcified, hypomatura-
tion, and hypomaturation-hypoplastic with taurodontism* Correspondence: ntaka@tokushima-u.ac.jp
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[1,2]. Several genes responsible for AI such as AMELX,
AMBN, ENAM, MMP20, KLK4, DLX3, WDR72, FAM83H,
and FAM20A have been so far reported [3-6]. Mutations
of AMELX cause X chromosome-linked AI. Mutations of
AMBN, ENAM, DLX3, and FAM83H cause autosomal
dominant AI. For autosomal recessive AI, mutations of
ENAM, MMP20, KLK4, WDR72, and FAM20A have
been demonstrated as shown in Table 1. However, not all
causative genes for AI-related disease have been identi-
fied to date [5-8].
Forward genetics using animal disease models is a
powerful approach to identify novel pathogenic genestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Causative genes of amelogenesis imperfecta








X-linked Amelx X X n.d.a [9-21]
Autosomal dominant Ambn 4 14 n.d. n.d.
Enam 4 14 no [14,22-27]
Dlx3 17 10 no [28]
Fam83h 8 7 n.d. [29-34]
Autosomal recessive Enam 4 14 no [35,36]
Mmp20 11 8 no [26,37-39]
Klk4 19 1 no [40]
Wdr72 15 8 no [41]
Fam20a 17 10 no [3,4]
a n.d.: not determined.
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basis of gene functions. In this study, we focused on AI
using a disease model, AMI, which has been reported as
a spontaneous AI mutant rat with chalky white teeth iso-
lated from a colony of stroke-prone spontaneously hyper-
tensive rat (SHR-SP) strain [42] (Figure 1A). In general,
the surface of incisor enamel (solely on the labial side) in
rodent shows yellowish-brown color. The molecular
mechanisms of pigmentation are not yet clear, however,
it is observed to store the irons with ferritin in the amelo-
blasts at pigmentation stage [43]. The iron-ferritin com-
plex is transferred to lysosomes for degradation. Then,
metabolically processed iron is released from ameloblasts
and deposited on the surface of enamel matrix as a
yellowish-brown layer. The whitish appearance of incisors
indicates these processes are not complete, in terms of
the defects of ameloblast differentiation, and resulting
the enamel defect. The original SHR-SP strain, hereafter
referred to as WT strain, does not have any AI phenotype.
The AI phenotype in AMI is hypoplastic, and inherited
as an autosomal single recessive trait; however, the causa-
tive gene has not been determined yet [42]. In this study,
we clarified the genetic causes of autosomal recessive
AI in AMI, and dissected the possible function of SP6
in amelogenesis.Methods
Animals
Animal experiments were approved by the Ethics Com-
mittee for Animal Experiments of the University of
Tokushima (No.06105). Both SHR-SP and AMI rats
were supplied from Daiichi Seiyaku, Co., Ltd. and main-
tained at the animal facility in the University of Tokush-
ima. To investigate whether the Sp6 transgene can
rescue the AI phenotype in AMI rats, we crossed Sp6
transgenic (Tg) rats, which we generated previously [43],with AMI rats to generate a Sp6 transgene homozygous
mutant (Ami/Ami+Tg), and used for further analyses.
cDNA sequencing of AI candidate genes and Sp6
The coding regions for Sp6 and other candidate genes
were amplified from molar cDNA samples from WT and
AMI rats by PCR using the primers shown in Table 2
with KOD plus DNA polymerase (TOYOBO, Osaka,
Japan) or PrimeSTAR HS DNA polymerase (Takara,
Shiga, Japan). PCR products were cloned into the
pGEM-T easy vector (Promega, Madison, WI). The
sequences of the products were analyzed with an ABI
PRISM 3100-Avant Genetic Analyzer (Applied Biosys-
tems, Foster City, CA).
Genotyping
Genomic DNA was isolated from the tail tips of the rats
and subjected to PCR analysis using the following four
primers in a single tube. For WT Sp6 amplification,
WT-Sp6.F-CTT (5′-GTC TGC AGC CGT GTC TT-3′),
rSp6.genomeR (5′-CTG GCA GCC TAA ATA ATA
TTC AAG CAG-3′), GAPDH-S (5′-CAT TGA CCT
CAA CTA CAT GG-3′), and GAPDH-AS (5′-CTC
AGT GTA GCC CAG GAT GC-3′) were used, and for
AMI Sp6, AMI-Sp6.F (5′-GTC TGC AGC CGT GTG
TC-3′) was used instead of WT-Sp6.F-CTT. Primer con-
centrations were as follows: Sp6, 0.75 mM; Gapdh,
0.25 mM. Sp6 (344 and 346 bp for WT and AMI, respec-
tively) and Gapdh (722 bp) were amplified using a ther-
mal cycler (94 °C for 4 min, 33 cycles of 94 °C for 30 s,
63 °C for 30 s, 72 °C for 30 s, and an extension step at
72 °C for 7 min) using Taq DNA polymerase (Promega).
Western blot analysis and immunocytochemistry
COS7 cells were transfected with a pCI-neo mammalian
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Figure 1 Identification of a 2-bp insertion in Sp6 in AMI rats. A. Representative phenotype of WT and AMI rats. Photographs show
mandibular incisors from each of the rats. B. The nucleotide sequence of Sp6 in wild-type (WT) and AMI rats. The 2-bp insertion is highlighted
(red). The square represents the premature stop codon. The amino acid sequence deduced from the codons is shown below the nucleotide
sequence. The altered amino acid sequence in Ami-SP6 is underlined. C. Schematic representation of SP6. The N-terminal region is located
to the left. Black boxes represent the position of the zinc finger motifs. The box with diagonal lines shows the altered amino acid sequence in
Ami-SP6. D. Western blot analyses. COS7 cells were transfected with an expression vector only (V) or with FLAG-tagged Wt- (W) or Ami- (A) cDNA.
Samples were blotted with FLAG antibodies. E. Subcellular localization of FLAG-tagged SP6 by immunocytochemical analysis. Red, FLAG-tagged
protein; Blue, Nuclei. F. Relative expression levels of Fst in WT and AMI molars.
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detection and immunocytochemical analysis were per-
formed as described previously [44].
Immunohistochemistry
Immunohistochemical analysis of postnatal day 1 incisors
was performed as described previously [44]. For longitu-
dinal sections of adult incisors, craniofacial regions were
isolated from adult rats after intracardiac perfusion with
phosphate-buffered saline containing 5 U/ml heparin fol-
lowed by fixation with 0.1 M phosphate buffer (pH 7.4)
containing 4 % paraformaldehyde. Postfixation was per-
formed by immersion of the dissected specimen into the
same fixative for 2 h. Postfixed samples were decalcified
in 10 % formic acid–4 % citric acid decalcification solu-
tion for 2 weeks or more at 4 °C. Decalcified maxillaewere trimmed and divided into three pieces vertically to
the longitudinal axis of the incisors, as described previ-
ously [43,45]. Each incisor segment was embedded in par-
affin, and a series of longitudinal sections (6-μm thick)
were prepared. The sections were treated with 3 % hydro-
gen peroxide in methanol for 20 min and boiled in
antigen-unmasking solution (Vector, Burlingame, CA,
USA) using a microwave. For immunostaining, samples
were blocked with 3 % horse serum in phosphate-
buffered saline (−), incubated with rabbit anti-rat SP6
antiserum [44] or normal rabbit serum as primary anti-
bodies (1:400), and incubated with Histofine Simple Stain
Rat MAX-PO (R) (Nichirei, Tokyo, Japan). DAB-buffer
tablets (Merck, Darmstadt, Germany) were used to
visualize signals. Sections were slightly cross-stained with
hematoxylin and mounted in Entellan New (Merck).
























aWdr72: We divided the coding region into two fragments (a and b)
for cloning.
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Deparaffinized longitudinal sections of the maxillary
incisors (12 μm) were stained with hematoxylin for
histological analysis. The ameloblast differentiation
stages were determined from the apical to the incisal
end of the incisors using a modification of Warshawsky
and Smith’s classification [46]. Presecretory ameloblasts
face pulp or dentin, and the secretory stage starts
from the position where the enamel matrix appears.
The maturation stage starts from the point where
the ameloblasts rapidly begin to decrease in size. In
the reduced stage, ameloblasts become cuboidal in
shape without a cytoplasmic region above the nucleus.
Images of the longitudinal sections of hematoxylin-
stained incisors were captured under a light micro-
scope connected to a CCD camera. The length of the
ameloblast layer at each stage was measured using the
ImageJ software (National Institutes of Health, Bethesda,
MD, USA).
Macroscopic observation
Incisors (7- to 9-week-old), digits, and whiskers (5- to 8-
month-old) were recorded with a digital camera. Thewhiskers of newborn pups were observed under a MZ16
stereomicroscope (Leica Microsystems, Wetzlar, Germany).
Linkage analysis
Sixty-two heterozygous (Wt/Ami) and 56 homozygous
(Ami/Ami) mutant rats were examined to determine the
correlation between AI and Ami. The JoinMap 4 soft-
ware (Kyazma, Wageningen, Netherlands) was used for
genetic linkage analysis.
X-ray analysis
Radiographs of rat teeth were obtained using MCT-
CB100MF (Hitachi Medico, Tokyo, Japan). The X-ray
analysis system was operated at a 50 kV accelerating
voltage with a 100 mA probe current.
Results and discussion
To explore the causative gene of AMI, we first examined
the sequences of the coding region of all reported causa-
tive genes for autosomal recessive AI, such as Enam,
Mmp20, Klk4, Wdr72, and Fam20a using total RNA of
day 6 AMI rat molars and compared these with those of
WT rats. We did not find any mutations among them
(summarized in Table 1), suggesting that a novel gene
may cause AI.
We next examined the Sp6 gene, which has been iden-
tified as a key player in tooth development [47,48]. SP6
is a member of the SP/KLF family of transcription fac-
tors, which have three tandem zinc finger domains of
the classical C2H2 type at the C-terminal region [48,49].
Loss-of-function analyses demonstrated that deficiency
of Sp6 in mice leads to malformation of teeth, hair,
digits, and lungs [50,51]. In particular, tooth anomalies
are observed including supernumerary teeth (hyperdon-
tia), abnormal dentin crystal structure, and enamel agen-
esis [50,51]. In addition, our in vitro gain-of-function
studies of SP6 identified several downstream target
genes in the dental epithelial cell line [44,52]. These
findings indicate that SP6 may play important roles
in ameloblast differentiation. When we performed the
sequence analysis of Sp6, we found a 2-bp insertion
between the nucleotide positions 965 and 966 in the
coding region of Sp6 in AMI rats (Figure 1B). This inser-
tion caused a frameshift mutation with the addition of
11 cryptic amino acid residues from amino acid position
323 of SP6, disrupting the third zinc finger domain of
SP6 (Figure 1C). To confirm whether the inserted Sp6
(Ami) could be translated into a protein in cells, we
transduced a CMV promoter-driven FLAG-tagged Wt
(wild type-Sp6) or FLAG-tagged Ami expression vector
into COS7 cells. The anti-FLAG antibody could detect
both the Wt and Ami-type SP6 protein on western blot
analysis (Figure 1D). Furthermore, subcellular localization
of Ami-SP6 was detected mainly in the nuclei and, to
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Furthermore, we examined the expression level of follis-
tatin (Fst) mRNA in postnatal day 6 (d6) molars from
WT and AMI rats, because we previously demonstrated
that Fst is one of the SP6 downstream target genes [44].
Fst expression was higher in AMI molars than in WT
molars (Figure 1F). These results demonstrated that Ami-
SP6 can be translated and located in the same manner as
Wt-SP6, but it has different effects on downstream target
gene expression.
To determine whether the 2-bp insertion in Sp6 corre-
lates with the AI phenotype in AMI rats, we performed
a linkage analysis. F1 rats were backcrossed with AMI to
obtain descendants carrying Ami either heterozygously
or homozygously. Although the color of the incisors in
the first backcross generation was yellowish brown when
the rats were heterozygotes with both Wt and Ami, Ami
homozygote rats had chalky white incisors (Figure 2B).
The Sp6 genotypes in WT, AMI, and their F1 hybrids
rats were analyzed by genomic PCR (Figure 2A), and we
confirmed that all AMI rats were homozygous for Ami.
Linkage analysis with 62 heterozygous (Wt/Ami) and 56
homozygous (Ami/Ami) mutant rats revealed that the
AI phenotype and Ami homozygosity were strongly
linked with a LOD score of 35.46.
Sp6 is located in rat chromosome 10q31, and this
locus is well conserved in human chromosome 17q21.
There are several tooth-related genes and family mem-
ber genes within 2 Mb of Sp6 (Figure 2C). Sp2 is a mem-
ber of the same family as Sp6 [49]. Dlx3 has been
reported as a causative gene for autosomal dominant AI
[6], and Dlx4 is located next to Dlx3 [53]. Ngfr, also
known as p75NTR, has been reported to be important
for early ameloblast differentiation [54]. Since we found
a strong link between this locus and the AI phenotype
associated with Ami, we further analyzed these genes by
cDNA cloning and sequencing in order to eliminate can-
didate AI causative genes. We could not find any muta-
tions in Sp2, Dlx3, Dlx4, or Ngfr genes using d6 AMI
molar RNA as a result (data not shown).
In order to distinguish Wt-SP6 from Ami-SP6, we pre-
pared rabbit polyclonal antibodies against specific pep-
tides for Wt-SP6 (amino acid residues 362–376) [44]. The
specificity of the antibodies was confirmed using cell
lysates of COS7 cells transfected with FLAG-tagged Wt
or FLAG-tagged Ami by western blot analysis (Figure 2D).
Next, we examined endogenous SP6 localization in the
mandibular incisors of WT and AMI newborn pups
by immunohistochemical analysis. In WT incisors, SP6
was detected in the nuclei of early secretory ameloblasts
and contralateral odontoblasts, whereas no signal was
observed in AMI incisors (Figure 2E).
Ameloblast differentiation is morphologically classified
into presecretory, secretory, and maturation stages [46,55].In this classification, the reduced stage is treated as a sub-
stage of the maturation stage. In order to verify the func-
tional relationship between AI and SP6 protein in detail,
we divided ameloblast differentiation into five stages:
presecretory; early secretory; late secretory; maturation;
and reduced. We then analyzed the localization of the
SP6 protein in the ameloblasts of maxillary incisors from
6-week-old rats (Figure 3A). In Wt/Ami rats, SP6 signals
were strong in the presecretory and early secretory amelo-
blasts and weak in the contralateral odontoblasts. SP6 sig-
nals were not detected in late secretory, maturation, and
reduced stage ameloblasts (Figure 3A, top panels). On the
other hand, homozygotes with the mutant Sp6 (Ami/Ami)
did not express the WT-SP6 protein at all, and defective
ameloblast morphology was observed, such as shortened
cells with immature polarization compared to the corre-
sponding regions in Wt/Ami rats (Figure 3A, third panel).
To investigate whether the Sp6 transgene can rescue
the AI phenotype in AMI rats, we then crossed Sp6
transgenic (Tg) rats with AMI rats to generate a Sp6
transgene homozygous mutant (Ami/Ami+Tg). The
Sp6 Tg rat model was recently established by the intro-
duction of a human CMV immediate early enhancer/
promoter-driven Sp6 coding sequence into Sprague–
Dawley rats [43] Since tooth development is also driven
by epithelial-mesenchymal interaction, we have used
CMV enhancer/promoter to expect SP6 expression in
both ameloblasts and odontoblasts. In Ami/Ami+Tg
rats, the morphology of ameloblasts was similar to that
observed in Wt/Ami rats from secretory to maturation
stages (Figure 3A, fourth panel). The ameloblasts in
Ami/Ami+Tg rats were aligned, well polarized, and their
cellular height was restored to the levels similar to those
in Wt/Ami rats (Figure 3A, top panels). However, tooth
color, enamel calcification, and enamel matrix expres-
sion could not be rescued (data not shown). Subse-
quently, we examined SP6 expression in Ami/Ami+Tg
rats. We could not detect any Wt-SP6 protein in the
regions corresponding to the presecretory, secretory,
and reduced stages in Ami/Ami+Tg rats, except for
exclusive expression in maturation stage ameloblasts
(Figure 3A, fourth panel). Consistent with these results,
Wt-SP6 signals were detected in maturation stage amelo-
blasts, in addition to both presecretory and secretory ame-
loblasts, in the Sp6 transgene heterozygous mutants (Wt/
Ami+Tg) (Figure 3A, second panel). One of the possible
reasons for the failure to rescue the AI phenotype is the
silencing of Sp6 transgene expression at the correct time
and region because we recently found that SP6 is a short-
lived protein (t1/2 ; 40 min) under the control of a prote-
asome pathway [52] and epigenetic mechanisms [56].
Next, we measured the length of the ameloblast layer
at each differentiation stage using longitudinal sections
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Figure 2 Linkage analysis between Sp6 and AI in AMI rats. A. Genomic PCR products amplified by WT- (upper panel) or AMI- (lower panel)
Sp6-specific primers. Sample numbers and the characteristics of the animals are denoted above the gel image. B. The color of the incisors was
examined. Pups derived from the cross between F1 and AMI rats were sorted by the Sp6 genotype to determine the correlation between
Sp6 and AI in AMI rats (Wt/Ami, n = 62; Ami/Ami, n = 56). C. Schematic diagram of focal gene localization in rat chromosome 10q31–10q32.1.
D. Western blot analyses. COS7 cells were transfected with expression vector only (V) or with FLAG-tagged Wt- (W) or Ami- (A) cDNA. Samples
were blotted with the indicated antibodies. E. Immunohistochemical analysis of incisors from newborn pups. Sections from secretory stage
incisors of WT rats and those of the corresponding region from AMI rats were stained with the anti-Wt-SP6 antiserum (SP6) or preimmune rabbit
serum (Pre). Signals were obtained from DAB (brown). Sections were counterstained with Hematoxylin. Scale bar: 100 mm. A, ameloblasts; O,
odontoblasts; P, pulp.
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function (Figure 3B). In Ami/Ami incisors, the length of
the ameloblast layer at the secretory and maturation
stages was shorter, and the reduced stage was elongated
compared with the Wt/Ami incisors (Figure 3B). In Wt/
Ami+Tg and Ami/Ami+Tg rat incisors, we found that
the length of the maturation stage ameloblast layer was
longer than that of the non-Tg controls Wt/Ami and
Ami/Ami, but the length of their reduced stage was
much shorter compared with that of the same non-Tgcontrols. These results suggested that SP6 expression
regulates cell morphology by an unknown mechanism.
However, further analyses are necessary to confirm the
molecular mechanism.
Sp6-deficient mice have several developmental abnor-
malities such as hyperdontia (supernumerary), enamel
agenesis, oligodactyly, syndactyly, and hairless pheno-
types [50,51,57]. Therefore, we carefully examined other
organogenesis processes in AMI rats that required SP6.
The whiskers were present, but curly, in newborn AMI
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Figure 3 Analyses of longitudinal sections of the maxillary incisors of 6-week-old rats. A. Immunohistochemical analysis. Incisor sections
were immunostained with antiserum against rat Wt-SP6. The sections were prepared from rats heterozygous (Wt/Ami) or homozygous (Ami/Ami)
for mutant Sp6. Animals were sorted based on the transgenic Sp6 (Tg) genotype. Scale bar, 100 mm. Ab, ameloblasts; Em, enamel matrix;
Es, enamel space; Ob, odontoblasts. B. The length of the ameloblast layer for the indicated differentiation stages. Columns represent the average
of two to three independent samples; bars indicate standard deviation. Statistical significance was evaluated by unpaired t tests for an indicated
set of data. *p< 0.05, **p< 0.01.
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In adulthood, the whiskers were feeble in AMI rats, but
not in WT rats (Figure 4B). The number of teeth and
their structure in both WT and AMI rats were normal
as judged by X-ray analyses, except for enamel formation
in AMI rats (Figure 4C). Because of this enamel defect,
the incisors of AMI showed less-sharp ends of incisor
tips and elongation of incisor length due to impossible
grinding and continuous growing.
Furthermore, we observed normal numbers and
morphology of the digits of both the forelimbs and hin-
dlimbs of AMI and WT rats (Figure 4D). Basically, the
AMI model shows only the AI phenotype. We summar-
ized the phenotypic comparison between AMI rats and
Sp6-deficient mice in Table 3.
Recently, there was a notable report of a frame-
shift mutation of Sp7/Osterix in a patient that causeda similar disruption of the third zinc finger domain
with additional amino acids and resulted in autosomal
recessive osteogenesis imperfecta (OI) [59]. The known
OI causative genes are restricted to type I collagen
metabolic pathway, while Sp7/Osterix is a member of
the SP/KLF family, which plays an essential role in
osteoblast differentiation as a downstream target of
RUNX2 [60]; therefore, it was an unexpected finding
that a Sp7/Osterix mutation could cause OI. Whereas
Sp7/Osterix-deficient mice could not survive [60], the
OI phenotype of the frameshift mutant is far milder.
Our study revealed a similar relationship between the
Sp6 frameshift mutation and AI as that between the
Sp7 frameshift mutation and OI. So far, there have been
no other reports of the association between an Sp6
mutation and AI patients, but our findings could
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Figure 4 Organogenesis requiring Sp6 activity. A. Whiskers of rats at postnatal day 1. Each Sp6 genotype in the 1st backcrossed generation
was examined. (Wt/Ami, n = 13; Ami/Ami, n = 21) B. Whiskers of adult rats. WT and AMI rats were examined when they were 6–8 months old
(WT, n = 3; AMI, n = 14) C. X-ray analysis of the maxillae (Max) and mandibles (Man) of WT (1, 2) and AMI (3, 4) rats. Molars (1, 3) and incisors (2, 4)
are highlighted (WT, n = 2; AMI, n = 2) D. Normal number of digits in AMI rats. Digits of the left (1, 3) and right (2, 4) limbs of WT (1, 2) and AMI
(3, 4) rats are shown. Upper panels, forelimb; lower panels, hindlimb (WT, n = 3; AMI, n = 14).
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of AI.
SP6 has three tandem zinc finger domains of the clas-
sical C2H2 type at the C-terminal region, which is com-
mon among SP/KLF family members [48,49]. Each
finger recognizes the specific nucleotide sequences and
contributes to the binding strength to DNA. In addition,
the finger plays a role of the interface with the regulatory
protein(s) [61]. SP1 is a well-characterized member of
the SP/KLF family, and all three zinc fingers are essential
for binding to importin alpha and contribute to nuclear
localization [62]. Here, we identified a novel frameshift
mutation caused by a 2-bp insertion in the Sp6 codingsequence, resulting in disruption of the third zinc finger
domain with an addition of an unrelated 11 amino acids
(Figure 1B,C). This SP6 mutant form could enter the
nuclei (Figure 1E). Our results indicate that the SP6
mutant form may have the following effects: 1) decrease
in the affinity of DNA binding, and either loss or reduce
of SP6 function as a transcription factor (Figure 1F);
2) decrease in the recruitment of interacting molecule
(s), and a change in the gene expression pattern; 3) a
novel recruitment or disappearance of protein–protein
interactions through the cryptically added 11 amino acids;
4) a dominant-negative effect by chelating the regulatory
domain interacting protein(s) at the N-terminal region of
Table 3 Abnormalities in AMI rats and Sp6-deficient mice




Teeth Number Normal Excess (hyperdontia)
Enamel Thin, calcified Absence or thin
Ameloblasts
- Nuclear Polarized Not well-polarized




Hair Normal Short, alopecia,
no fur
Whisker Pups (at birth) Curly Rare, short, curly,
alopecia
Adult Feeble Delayed appearance
Digits Normal Syndactyly,
oligodactyly
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sense transcript. Further investigations are necessary to
confirm the possible effects induced by the SP6 mutant
and understand the molecular basis for amelogenesis.
Amelogenesis imperfecta is an inherited disorder of
enamel formation with both clinical and genetic hetero-
geneity [1,2]. In many cases, the nomenclature of the
inherited diseases has been developed based on the
phenotypes and inheritance patterns. Therefore, it is
difficult to distinguish the highly variable clinical phe-
notypes. Recently, molecular basis of these inherited dis-
eases are reorganized based on the phenotype-genotype
relationship. Online Mendelian Inheritance in Man
(http://www.ncbi.nlm.nih.gov/omim) is a well-organized
and updated genetic disease database. However, there is
very limited description about the autosomal recessive
form of hypoplastic AI in the section of amelogenesis
imperfect. Here, we demonstrated the novel genetic
linkage between SP6 frameshift mutation and auto-
somal recessive type of AI using a spontaneous AI
animal model. We presents the evidence for a novel
genotype–phenotype correlation of hereditary enamel
defect, and it is encouraged to screen Sp6 gene in the
of AI patients with unknown cause. Further studies on
molecular basis of SP6 in amelogenesis could promote
the development of the therapeutic application, such as
gene therapy.
Conclusion
We propose the addition of Sp6 mutation in the AI clas-
sification as a new molecular criterion to properly diag-
nose and to apply it to development of therapeutic tools.
Further analyses for the regulation of the temporospatial
expression of SP6 and its function may clarify the
mechanisms of AI disease and amelogenesis.Abbreviations
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